** Medtech company Becton Dickinson's BDX.N shares rise 1.80% to $252.06 premarket
** Activist investor Starboard Value has taken a stake in BDX and is pushing the company to sell its life sciences unit, the Financial Times reported, citing people familiar with the matter
** The size of Starboard's stake is unclear, the report said
** The hedge fund has met company's management team and sent a letter to the board imploring the company to sell the unit, which makes products used in clinical and research laboratories, according to the report
** BDX and Starboard did not immediately respond to a Reuters request for comment
** Stock had fallen ~7 in 2024
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。